about
Intracellular drug bioavailability: a new predictor of system dependent drug disposition.CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.Intracellular Drug Bioavailability: Effect of Neutral Lipids and PhospholipidsA Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (fu,cell)Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4533-7761
@en
name
A Treyer
@ast
A Treyer
@en
A Treyer
@nl
type
label
A Treyer
@ast
A Treyer
@en
A Treyer
@nl
prefLabel
A Treyer
@ast
A Treyer
@en
A Treyer
@nl
P106
P31
P496
0000-0002-4533-7761